Ares Management’s Privia Health PRVA Stock Holding History

Ares Management’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-343,094	Closed	-$8.08M	–	50
2021 Q3	$8.08M	Hold	343,094	–	–	0.27%	26
2021 Q2	$15.2M	Buy	+343,094	New	+$12.7M	0.54%	19

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ares Management's PRVA Position: Q4 2021 in Review

Ares Management sold out of Privia Health (PRVA) in Q4 2021, closing a stake of 343,094 shares — an estimated $8.08M sold.

Ares Management first reported a position in PRVA in Q2 2021 and held it in 2 quarters. The position peaked at $15.2M in Q2 2021. 122 funds tracked by Wall St. Rank hold PRVA as of Q4 2021.

Ares Management reported no remaining Privia Health position as of Q4 2021 after selling out during the quarter.
Ares Management sold 343,094 Privia Health shares in Q4 2021, an estimated $8.08M.
Ares Management first reported a position in Privia Health in Q2 2021 and held it in 2 quarters.
Ares Management's Privia Health position peaked at $15.2M in Q2 2021.
122 funds tracked by Wall St. Rank held Privia Health as of Q4 2021.

Based on Ares Management's 13F filing for Q4 2021, filed 14 Feb 2022.